$VTR

Ventas, Inc.

6
5
0

No SEC Form 4 filings for $VTR in the last 30 days.

Med

Diamond Hill Capital Management Inc. Sells 12,199 Shares of Ventas, Inc. $VTR

Diamond Hill Capital Management Inc. reduced its stake in Ventas, Inc. (NYSE:VTR) by 8.3% in the fourth quarter, selling 12,199 shares and retaining 135,229 shares valued at approximately $10.46 million. Despite missing EPS estimates, Ventas reported strong revenue growth of 22% year-over-year and announced a $0.52 per share quarterly dividend. Analysts maintain a "Moderate Buy" rating with an average target price of $95.00 for the healthcare REIT.

Apple stock hits all-time high, reaching 311.18 USD

Apple Inc. stock has hit an all-time high of $311.18, marking a 59.11% surge over the last year and boosting its market capitalization to $4.57 trillion. The company's strong performance is attributed to robust product demand, strategic innovations, and revenue growth. While analysts have revised earnings upwards and the company boasts a perfect Piotroski Score, InvestingPro's Fair Value analysis suggests the stock is currently overvalued.

Mizuho raises Ventas stock price target to $98 on higher estimates

Mizuho raised its price target on Ventas Inc. (NYSE:VTR) to $98 from $94, maintaining an Outperform rating due to higher funds from operations (FFO) and adjusted FFO (AFFO) estimates for 2026 and 2027. The updated target implies an 11% upside from current levels, though InvestingPro analysis suggests the stock might be overvalued. This follows Ventas' strong first-quarter 2026 earnings, which surpassed Wall Street expectations for both EPS and revenue, and an increase in its ATM Sales Agreement to $3 billion.